FSCA and Field Safety Notices Under UK MDR 2002 Part 4A

1. Key takeaways

Under reg 44ZJ, before taking any field safety corrective action (FSCA), a manufacturer must in principle first complete a risk assessment of the proposed action and submit an initial report and the proposed field safety notice (FSN) to the Secretary of State; in urgent situations the report may follow after the action has been implemented. reg 44ZK imposes an additional, independent duty: where an FSCA is taken outside Great Britain (Northern Ireland excluded) for a similar device, MHRA must be notified. The FSN must identify the device and include the unique device identification in a searchable format.

The combined effect is that a recall decision taken anywhere in the world can create obligations in Great Britain on the same day, and that the sequence of steps in the United Kingdom is fixed by law rather than by company preference. Manufacturers used to markets where corrective actions are reported after the fact must relearn the order of operations for Great Britain, and must keep the UKRP in the loop from the first hours of any emerging quality signal, because the UKRP appears in the statutory content of the initial report and is likely to be the first point of contact for any MHRA follow-up. Preparation matters more here than in almost any other part of the regime, since the deadlines compress exactly when a company is under the greatest internal pressure.

2. Legal basis

• UK MDR 2002 (SI 2002/618, as amended): reg 44ZJ(1)–(6) (FSCA and FSN) and reg 44ZK (FSCA outside Great Britain).
• SI 2024/1368 (made on 16 December 2024, in force on 16 June 2025): reg 4 inserted Part 4A into UK MDR 2002.
• reg 44ZJ(2): the initial report must contain the manufacturer’s name and contact details, the name and contact details of the UKRP (where one has been appointed), a description of the device (including the UDI), a description of the FSCA and the way it is proposed to be implemented, the reasons for taking the FSCA justified by a risk assessment, and the number of devices placed on the market in, or put into service in, Great Britain and an estimate of the number of affected users.
• reg 44ZJ(6): the FSN must identify the device concerned and include the unique device identification in a searchable format.

3. Expert insights

Insight one: FSCA reporting is report first, act second — not act first, report later. reg 44ZJ(1) makes clear that, except in the urgent situations covered by paragraph (4), the risk assessment must be completed and the initial report and proposed FSN submitted before the FSCA is taken. This is a key difference from the report-after-action approach of many other markets — getting the sequence wrong is itself a breach, even if the substance of the corrective action is sound. Companies should therefore treat the filing sequence as a controlled step in the quality system, with sign-off before any customer communication goes out in Great Britain.

Insight two: the statutory content of the initial report includes UKRP information. reg 44ZJ(2)(b) requires the initial report to state the name and contact details of the UKRP, where one has been appointed. This makes the UKRP a statutory contact node in the FSCA scenario, and the speed of its response directly affects the quality of the report. A UKRP that is unreachable during the critical first days of a recall is a structural weakness in the compliance chain, not a formality on file.

Insight three: FSCAs taken outside Great Britain must also be notified. reg 44ZK provides that where an FSCA is taken outside Great Britain (Northern Ireland is expressly excluded) for a device similar to one placed on the market in Great Britain, MHRA must be notified. This means that a recall action in the EU or the US can trigger a UK notification duty — the scenario most easily missed by multinational companies, because the internal escalation typically closes when the local market action is complete. The notification assessment must therefore be written into the global recall workflow, not left to memory.

Insight four: the FSN must actually reach users. reg 44ZJ(5) requires the manufacturer to take all reasonable steps to ensure the FSN reaches users of the device; reg 44ZJ(6) requires the FSN to include the UDI in a searchable format. Evidence of distribution of the notice — delivery records, acknowledgements from key customers — should be retained, because reach is exactly what an inspector will probe after any corrective action.

4. Practical recommendations

GRZAN recommends moving FSCA handling forward in the process: as soon as any quality signal appears that could trigger a recall or field correction, a pre-assessment of the FSCA should start, with the risk assessment, initial report and FSN draft prepared in parallel and the UKRP notified at the same time. Waiting until the decision to recall is formally taken costs days that the sequence rules do not allow. A global FSCA linkage and notification mechanism should also be established: any corrective action for a similar device in any jurisdiction must be reviewed by a designated person for a possible Great Britain notification under reg 44ZK, with the review result recorded. As a practical estimate, companies that pre-draft FSN templates with searchable UDI fields and standing distribution lists can cut their reaction time substantially, because the notice content is largely administrative once the technical assessment is done. The mechanism should be tested annually through a tabletop exercise involving the UKRP.

5. Verification checklist

• □ The FSCA process has been set up on a report-first-act-later basis
• □ The initial report template includes the name and contact details of the UKRP
• □ The FSN template includes the UDI in a searchable format
• □ A notification assessment mechanism for FSCAs outside Great Britain (excluding Northern Ireland) has been established
• □ A mechanism for retaining evidence that the FSN reached users has been established

Regulatory information verified as of 29 October 2026.

• Appointment of the UK Responsible Person (UKRP) and support with signing the letter of authorisation
• Full-process MHRA registration (DORS) filing and account lifecycle management
• Device classification determination, GMDN code selection and annual registration fee calculation
• Dual-route design for Great Britain and Northern Ireland, including UK(NI) solutions
• Establishment of post-market surveillance (PMS) systems, preparation of PMSR/PSUR and submission of vigilance reports
• Emergency handling of serious adverse incidents and field safety corrective actions (FSCA)
• Monitoring of UK regulatory changes and compliance gap assessment

For post-market compliance support in the UK market — vigilance reporting, recall management and MHRA inspection response — contact GRZAN at info@grzanglobal.com.